Delgocitinib approved to treat adult patients with moderate to severe chronic hand eczema

The Medicines and Healthcare products Regulatory Agency has approved the medicine delgocitinib (Anzupgo) to treat moderate to severe chronic hand eczema in adults when topical corticosteroids are inadequate or inappropriate.

Follow this news feed: